20-F: P.V. Nano Cell Reports 2023 Financial Results, Cites Going Concern Uncertainty

P.V. Nano Cell reports a net loss of $2.1 million for 2023 and expresses substantial doubt about its ability to continue as a going concern due to limited revenues and outstanding liabilities.

Summary

• P.V. Nano Cell Ltd. reported a net loss of approximately $2.1 million for the year ended December 31, 2023, and an accumulated deficit of approximately $42.7 million as of the same date.
• The company's revenues decreased by 21% to $478,584 in 2023 compared to $603,359 in 2022.
• The company is in default in repayment of convertible notes, which as of December 31, 2023, aggregated to approximately $1.5 million (including principal and interest).
• As of December 31, 2023, the company had outstanding current liabilities towards the Israel Innovation Authority (IIA), service providers, and suppliers in the aggregate amount of approximately $3.5 million.
• The company's independent registered public accounting firm has expressed substantial doubt about its ability to continue as a going concern.
• The company believes it needs to raise significant additional funds before it has significant cash flow from operations.
• As of December 31, 2023, the company had a cash balance of $629,957 and estimates it can fund operations through July 2024.
• The company is seeking additional capital through debt or equity financings, but there is no assurance that additional funds will be available on acceptable terms.
• The company's management concluded that its internal control over financial reporting was not effective as of December 31, 2023.
• The company is subject to risks associated with operating in Israel, including political, economic, and military instability.

Sentiment

Score: 3

Explanation: The document presents a concerning financial situation with significant losses, going concern uncertainty, and ineffective internal controls. While there are some positive aspects, the overall tone is negative from an investment perspective.

Positives

• The company increased its facility's production capacity during 2023 to support current customer demand.
• The company is developing what it believes is the first single crystal copper-based nano-metric paste and ink for mass-production of printed electronics.
• The company is focusing its efforts on demonstrating the advantages of its Sicrys technology to dedicated customers.
• The company is partnering with leading printing technology manufacturers to supply its solutions to potential customers.

Negatives

• The company has a limited operating history and has incurred significant losses since its inception.
• The company's history of net losses has raised substantial doubt regarding its ability to continue as a going concern.
• The company will need significant additional capital on an immediate basis, which it may be unable to obtain.
• The company has generated only minimal revenue from product sales and may never be profitable.
• The company currently has minimal marketing and sales capabilities.
• The company's management conducted an evaluation of the effectiveness of its internal control over financial reporting and concluded that its internal control over financial reporting was not effective as of December 31, 2023.

Risks

• The company's business, financial condition, and results of operations could be materially and adversely affected by political, economic, and military instability in Israel.
• The Israeli government grants the company has received for research and development expenditures restrict its ability to manufacture products and transfer technologies outside of Israel and require it to satisfy specified conditions.
• Exchange rate fluctuations, primarily between the U.S. dollar and the NIS currencies, and inflation may negatively affect the company's results of operations.
• The market price of the company's ordinary shares may fluctuate significantly.
• Because the company's ordinary shares are traded as a penny stock, it may be more difficult for investors to sell the ordinary shares, and the market price of the ordinary shares may be adversely affected.
• The health effects of nanotechnology are unknown.
• The company is subject to risks resulting from fluctuations in the price of silver and other raw materials.
• The company faces competition in the markets in which it operates and its competitors may develop products that are similar to, more advanced than, or more effective than ours, which may adversely affect our financial condition and our ability to successfully commercialize our products and technologies.

Future Outlook

The company anticipates needing to raise additional capital to fund operations beyond July 2024 and to pay existing and future liabilities, but there is no assurance that additional funds will be available on acceptable terms.

Industry Context

The document provides insight into the challenges faced by a small company in the conductive ink and paste industry, including competition, technological advancements, and the need for continuous innovation. It also highlights the importance of government grants and strategic collaborations for such companies.

Comparison to Industry Standards

• The document mentions competition from companies developing silver-based and copper-based inks and pastes.
• It notes that many competitors have substantially greater financial, technical, and other resources.
• The document highlights the company's competitive advantages, including higher metal load at low viscosities, higher stability, and low resistivity.
• The document mentions the difficulty in producing nano-based inks in large-scale quantities, which creates a barrier to entry for competitors.

Legal Proceedings

• The company is involved in a lawsuit filed by a former employee of Digiflex, but the outcome is uncertain.

Related Party Transactions

• The company has employment and services agreements with its Active Chairman and executive officers.
• The company has entered into indemnification and exculpation agreements with its directors and executive officers.
• The company has entered into option agreements with its directors and executive officers.
• The company entered into a settlement agreement with Dolev and Dr. Fernando de la Vega with respect to amounts owed to Dolev under the DBG Services Agreement.
• The company has entered into investment agreements with certain existing shareholders in connection with private placements of its securities.

Stakeholder Impact

• Shareholders face the risk of dilution from future equity financings.
• Shareholders could lose confidence in the company's financial and other public reporting due to ineffective internal controls.
• Employees may be affected by potential cost-cutting measures or restructuring if the company's financial situation does not improve.
• Customers may be affected by potential disruptions in supply or service if the company faces financial difficulties.
• Suppliers and creditors face the risk of non-payment if the company is unable to meet its financial obligations.

Next Steps

• The company will need to raise additional capital to continue operations beyond July 2024.
• The company intends to take appropriate and reasonable steps to make the necessary improvements to remediate the deficiencies in internal control.
• The company plans to further increase production capacity in accordance with future customer demand, subject to sufficient available capital.

Key Dates

Keywords

conductive inks, conductive pastes, nano cell, PVNNF, Sicrys, printed electronics, solar, financial results, going concern, P.V. Nano Cell